Unity Biotechnology Inc (UBX)
NASDAQ:UBX
Holding UBX?
Track your performance easily

Unity Biotechnology (UBX) Financial Statements

709 Followers

Unity Biotechnology Financial Overview

Unity Biotechnology's market cap is currently ―. The company's EPS TTM is $-1.981; its P/E ratio is -0.73; Unity Biotechnology is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is $-0.40. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 1.47M$ 1.47M-$ 976.00K$ 965.00K
Gross Profit$ 1.47M$ 1.47M-$ 976.00K$ 965.00K
EBIT$ -5.28M$ -5.79M$ -1.50M$ -14.82M$ -11.23M
EBITDA$ -4.80M$ -5.56M$ -1.27M$ -14.51M$ -10.97M
Net Income Common Stockholders$ -5.28M$ -5.79M$ -1.50M$ -15.29M$ -12.21M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 33.98M$ 36.33M$ 43.20M$ 45.94M$ 69.09M
Total Assets$ 53.52M$ 58.86M$ 65.69M$ 69.27M$ 101.01M
Total Debt$ 21.66M$ 22.61M$ 23.54M$ 24.43M$ 43.08M
Net Debt$ -12.32M$ -13.73M$ -19.66M$ -21.51M$ -26.01M
Total Liabilities$ 33.77M$ 34.88M$ 37.29M$ 33.06M$ 51.60M
Stockholders Equity$ 19.78M$ 24.03M$ 28.35M$ 36.21M$ 49.43M
Cash Flow-
Free Cash Flow$ -4.58M$ -5.16M$ -7.46M$ -7.12M$ -11.08M
Operating Cash Flow$ -4.58M$ -5.18M$ -7.58M$ -7.11M$ -11.08M
Investing Cash Flow$ 4.67M$ -7.19M$ 15.11M$ 14.25M$ 9.85M
Financing Cash Flow$ 68.00K-$ 4.39M$ -18.38M$ -2.63M
Currency in USD

Unity Biotechnology Earnings and Revenue History

Unity Biotechnology Debt to Assets

Unity Biotechnology Cash Flow

Unity Biotechnology Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis